Stroke prevention in patients from Latin American countries with non‐valvular atrial fibrillation: Insights from the GARFIELD‐AF registry
Author(s) -
JerjesSanchez Carlos,
Corbalan Ramon,
Barretto Antonio C. P.,
Luciardi Hector L.,
Allu Jagan,
Illingworth Laura,
Pieper Karen S.,
Kayani Gloria
Publication year - 2019
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23176
Subject(s) - medicine , atrial fibrillation , antithrombotic , stroke (engine) , latin americans , oral anticoagulant , major bleeding , anticoagulant therapy , cardiology , warfarin , mechanical engineering , linguistics , philosophy , engineering
Atrial fibrillation (AF) is an important preventable cause of stroke. Anticoagulation (AC) therapy can reduce this risk. However, prescribing patterns and outcomes in patients with non-valvular AF (NVAF) from Latin American countries are poorly described.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom